AstraZeneca concludes equity investment in Cellectis
AstraZeneca has concluded an equity investment in clinical-stage biotechnology company Cellectis following a deal signed in November 2023.…
£68,063
-50,07%
Echtzeit-Aktienkurs Astrazeneca PLC (Spons. ADRs)
Bid:
Ask:
Nachrichten zur Astrazeneca PLC (Spons. ADRs) Aktie
AstraZeneca completes Cellectis equity investment
7 May 2024
AstraZeneca completes equity investment agreement with Cellectis
AstraZeneca today announced the successful completion of an equity investment with Cellectis,…
The Zacks Analyst Blog Highlights AstraZeneca, Qualcomm, FedEx, American International and Baker Hughes
AstraZeneca, Qualcomm, FedEx, American International and Baker Hughes are included in this Analyst Blog.…
ANGLE announces second assay with AstraZeneca as it deepens relationship with pharma giant
…
ANGLE inks £550,000 deal with AstraZeneca for prostate cancer detection, shares jump
ANGLE plc, the AIM-listed liquid biopsy company, has inked a major supplier agreement with pharmaceutical giant AstraZeneca. The £550,000 deal…